RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+4.61%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.3B
AUM Growth
+$1.3B
(-1.8%)
Cap. Flow
-$15.3M
Cap. Flow
% of AUM
-1.18%
Top 10 Holdings %
Top 10 Hldgs %
52.92%
Holding
72
New
14
Increased
18
Reduced
22
Closed
16
Top Buys
| 1 |
Boston Scientific
BSX
|
$41.5M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$40.3M |
| 3 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
$38.2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$29.3M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$26.3M |
Top Sells
| 1 |
RAD
Rite Aid Corporation
RAD
|
$49M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
$40.8M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$38.8M |
| 4 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$33.8M |
| 5 |
Incyte
INCY
|
$27.7M |
Sector Composition
| 1 | Healthcare | 79.19% |
| 2 | Communication Services | 1.61% |
| 3 | Industrials | 0.58% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Wave Life Sciences
WVE
$1.27B
| $18.3M | 1.37% |
+1,213,627
| New | +$18.3M |
|
27
CytomX Therapeutics
CTMX
$350M
| $14.4M | 1.08% |
+738,356
| New | +$14.4M |
|
|
HNT
28
DELISTED
HEALTH NET INC
HNT
| $12.4M | 0.93% |
181,029
+1,800
| +1% | +$123K |
|
|
ELGX
29
DELISTED
Endologix Inc
ELGX
| $9.97M | 0.75% |
+1,007,177
| New | +$9.97M |
|
|
OXFD
30
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $9.89M | 0.74% |
860,288
-167,844
| -16% | -$1.93M |
|
31
Charles River Laboratories
CRL
$7.99B
| $9.84M | 0.74% |
+122,400
| New | +$9.84M |
|
|
TRIV
32
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $9.73M | 0.73% |
1,462,762
-1,221
| -0.1% | -$8.12K |
|
33
Fate Therapeutics
FATE
$115M
| $7.99M | 0.6% |
2,371,001
+296,165
| +14% | +$998K |
|
|
PGND
34
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $7.56M | 0.57% |
239,616
+154,650
| +182% | +$4.88M |
|
|
BPMC
35
DELISTED
Blueprint Medicines
BPMC
| $7.29M | 0.55% |
276,687
-90,798
| -25% | -$2.39M |
|
|
GBT
36
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $7.07M | 0.53% |
218,718
-44,174
| -17% | -$1.43M |
|
37
DURECT Corp
DRRX
$60.2M
| $5.81M | 0.43% |
2,628,416
+15,100
| +0.6% | +$33.4K |
|
|
NVTA
38
DELISTED
Invitae Corporation
NVTA
| $5.42M | 0.41% |
660,129
| – | – |
|
|
CASC
39
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $5.18M | 0.39% |
2,331,300
-1,283,690
| -36% | -$2.85M |
|
40
ProQR Therapeutics
PRQR
$256M
| $4.84M | 0.36% |
557,193
-103,623
| -16% | -$899K |
|
41
Pfizer
PFE
$141B
| $4M | 0.3% |
+123,800
| New | +$4M |
|
42
Carisma Therapeutics
CARM
$15.5M
| $2.64M | 0.2% |
875,857
+27,506
| +3% | +$82.8K |
|
|
CFMS
43
DELISTED
Conformis, Inc. Common Stock
CFMS
| $2.17M | 0.16% |
125,709
-563,136
| -82% | -$9.74M |
|
|
CELG
44
DELISTED
Celgene Corp
CELG
| $1.2M | 0.09% |
+10,055
| New | +$1.2M |
|
45
iShares US Healthcare Providers ETF
IHF
$795M
| $562K | 0.04% |
+4,520
| New | +$562K |
|
|
CCXI
46
DELISTED
ChemoCentryx, Inc.
CCXI
| $512K | 0.04% |
63,189
-437,426
| -87% | -$3.54M |
|
|
SRRA
47
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $373K | 0.03% |
24,787
+6,396
| +35% | +$96.3K |
|
48
Standard BioTools
LAB
$493M
| $352K | 0.03% |
32,561
+7,978
| +32% | +$86.2K |
|
49
SPDR S&P Biotech ETF
XBI
$5.29B
| $317K | 0.02% |
4,530
-4,720
| -51% | -$330K |
|
|
KDNY
50
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $294K | 0.02% |
10,436
-5,620
| -35% | -$158K |
|